《大行報告》富瑞上調國泰(00293.HK)目標價至8.6元 評級「買入」
富瑞發表報告指國泰(00293.HK)2021年淨虧損約56億元至61億元,較該行及市場預期佳,意味2021年下半年錄得18億至23億元純利,較管理層的虧損預期有驚喜。
不過,今年一開首已是疲勢,主要是受更嚴格的機組人員檢疫措施影響,盈利重新受壓,管理層預期自今年2月起,每月消耗10億至15億元現金,加上運力遭到削減,貨運及客運運力只在疫情前的20%及2%水平。
富瑞預期直至2022年下半年前,客運數量仍然疲弱,但對該股維持「買入」評級,主要基於運力限制將隨本港疫情受控而緩慢放寬,以及公司仍有充足流動資金;目標價由8.4元調高至8.6元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.